Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$381.09 - $495.99 $338,407 - $440,439
-888 Reduced 37.26%
1,495 $676,000
Q1 2024

May 13, 2024

SELL
$308.3 - $463.55 $177,889 - $267,468
-577 Reduced 19.49%
2,383 $1.1 Million
Q4 2023

Feb 09, 2024

BUY
$289.29 - $409.7 $342,808 - $485,494
1,185 Added 66.76%
2,960 $1.12 Million
Q3 2023

Nov 09, 2023

SELL
$401.2 - $581.79 $25,676 - $37,234
-64 Reduced 3.48%
1,775 $733,000
Q2 2023

Aug 11, 2023

BUY
$500.0 - $659.0 $126,500 - $166,727
253 Added 15.95%
1,839 $1.04 Million
Q1 2023

May 12, 2023

SELL
$565.0 - $694.87 $154,245 - $189,699
-273 Reduced 14.69%
1,586 $995,000
Q4 2022

Feb 08, 2023

BUY
$551.1 - $688.5 $412,222 - $514,998
748 Added 67.33%
1,859 $1.04 Million
Q3 2022

Nov 10, 2022

SELL
$545.43 - $680.3 $40,907 - $51,022
-75 Reduced 6.32%
1,111 $627,000
Q2 2022

Aug 10, 2022

SELL
$605.0 - $763.25 $38,115 - $48,084
-63 Reduced 5.04%
1,186 $746,000
Q1 2022

May 16, 2022

SELL
$601.4 - $763.0 $748,743 - $949,935
-1,245 Reduced 49.92%
1,249 $891,000
Q4 2021

Feb 14, 2022

BUY
$650.15 - $802.0 $284,765 - $351,276
438 Added 21.3%
2,494 $1.76 Million
Q3 2021

Nov 15, 2021

SELL
$594.24 - $758.0 $71,903 - $91,718
-121 Reduced 5.56%
2,056 $1.43 Million
Q2 2021

Aug 13, 2021

SELL
$582.88 - $670.99 $159,709 - $183,851
-274 Reduced 11.18%
2,177 $1.35 Million
Q1 2021

May 12, 2021

SELL
$619.2 - $736.0 $45,820 - $54,464
-74 Reduced 2.93%
2,451 $1.57 Million
Q4 2020

Feb 11, 2021

BUY
$576.6 - $672.2 $70,345 - $82,008
122 Added 5.08%
2,525 $1.62 Million
Q3 2020

Nov 12, 2020

SELL
$620.1 - $689.89 $153,164 - $170,402
-247 Reduced 9.32%
2,403 $1.5 Million
Q2 2020

Jul 31, 2020

SELL
$610.05 - $713.9 $34,772 - $40,692
-57 Reduced 2.11%
2,650 $1.69 Million
Q1 2020

May 01, 2020

SELL
$615.5 - $751.4 $182,188 - $222,414
-296 Reduced 9.86%
2,707 $1.76 Million
Q4 2019

Feb 14, 2020

BUY
$688.5 - $846.15 $440,640 - $541,536
640 Added 27.08%
3,003 $2.26 Million
Q3 2019

Nov 14, 2019

BUY
$722.04 - $840.0 $374,738 - $435,960
519 Added 28.15%
2,363 $1.84 Million
Q2 2019

Aug 14, 2019

BUY
$837.83 - $927.0 $496,833 - $549,711
593 Added 47.4%
1,844 $1.57 Million
Q1 2019

May 14, 2019

SELL
$709.9 - $885.4 $907,962 - $1.13 Million
-1,279 Reduced 50.55%
1,251 $1.1 Million
Q4 2018

Feb 14, 2019

BUY
$667.94 - $785.7 $195,706 - $230,210
293 Added 13.1%
2,530 $1.87 Million
Q3 2018

Nov 14, 2018

BUY
$602.8 - $699.6 $293,563 - $340,705
487 Added 27.83%
2,237 $1.55 Million
Q2 2018

Aug 14, 2018

BUY
$568.25 - $635.8 $178,430 - $199,641
314 Added 21.87%
1,750 $1.05 Million
Q1 2018

May 15, 2018

BUY
$526.8 - $633.85 $503,620 - $605,960
956 Added 199.17%
1,436 $907,000
Q4 2017

Feb 14, 2018

SELL
$620.6 - $689.35 $91,848 - $102,023
-148 Reduced 23.57%
480 $302,000
Q3 2017

Nov 14, 2017

BUY
$608.7 - $680.0 $180,783 - $201,960
297 Added 89.73%
628 $422,000
Q2 2017

Aug 14, 2017

BUY
N/A
63 Added 23.51%
331 $213,000
Q1 2017

Nov 14, 2017

BUY
N/A
268
268 $126,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.